TrialCancer immunology, immunotherapy : CII2026
Envafolimab combined with lenvatinib and albumin-bound paclitaxel in previously treated advanced gastric/gastroesophageal junction (G/GEJ) adenocarcinoma: a prospective, phase II, multi-cohort trial.
Zhao Xiaoying et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.